DLL4 and neoplasm: Importantly, we show that Dll4 overexpression reduces vascular responsiveness to VEGF seeming indicated for concomitant application with VEGF-inhibitors and stabilizes tumor circulation allowing for more efficient chemotherapy delivery while at the same time reducing the formation of distant-site metastasis.